←
Rothstein Lab2,547 posts
Rothstein Lab avatar

Rothstein Lab

@Rothstein_Lab

Dr. Jeffrey Rothstein is a professor of neurology and neuroscience @HopkinsMedicine and is the founding director of @packardcenter. (trainee run)

◷ Joined April 2023▧ 36 Photos and videos
Suleyman Can Akerman avatar
⟳ Rothstein Lab retweeted
Suleyman Can Akerman@CanAkerman·Sep 3

Great to be part of #ALSNexus26 last week! I presented our work on modulating extracellular vesicles to inhibit dipeptide repeat propagation in C9-ALS, both in the Emerging Science session and as a poster. Great discussions across the ALS community. #ALS

Post attachmentPost attachment
Rothstein Lab avatar
Rothstein Lab@Rothstein_Lab·Aug 17

TDP-43-related cryptic splicing reflects pathological heterogeneity in amyotrophic lateral sclerosis link.springer.com/article/10…

Suleyman Can Akerman avatar
⟳ Rothstein Lab retweeted
Suleyman Can Akerman@CanAkerman·Aug 7

Multi-omics of C9orf72 spinal cord organoids reveal convergent molecular signatures and targets researchsquare.com/article/r…

ShorterLab avatar
⟳ Rothstein Lab retweeted
ShorterLab@ShorterLab·Aug 6

α-Synuclein blocks endoplasmic reticulum co-translational protein translocation early in Parkinson’s disease: nature.com/articles/s41467-0…

Rothstein Lab avatar
Rothstein Lab@Rothstein_Lab·Aug 5

Astrocyte dysfunction distinguishes monozygotic twin C9orf72 expansion carriers discordant for amyotrophic lateral sclerosis biorxiv.org/content/10.64898…

Rothstein Lab avatar
Rothstein Lab@Rothstein_Lab·Aug 5

Schwann Cell–Specific TDP-43 Rescue Improves Peripheral Nerve Myelin Pathology Without Altering Motor Behaviour in a Mouse Model of ALS biorxiv.org/content/10.64898…

Suleyman Can Akerman avatar
⟳ Rothstein Lab retweeted
Suleyman Can Akerman@CanAkerman·Jul 12

Intersting preprint: blocking VPS4a could keep TDP-43 out of exosomes without stopping exosome production. That would suggest that one might be able to block the neuron-to-neuron spread of pathology without shutting down normal vesicle trafficking. biorxiv.org/content/10.64898…

Rothstein Lab avatar
Rothstein Lab@Rothstein_Lab·Jul 12

Therapeutic targeting of the conserved region within the low-complexity domain of TDP-43 is neuroprotective and extends survival in amyotrophic lateral sclerosis mice nature.com/articles/s43587-0…

Rothstein Lab avatar
Rothstein Lab@Rothstein_Lab·Jul 6

An open-label Phase 2a study of fasudil in amyotrophic lateral sclerosis: safety and exploratory endpoints tandfonline.com/doi/10.1080/…